Detalhes bibliográficos
| Ano de defesa: |
2023 |
| Autor(a) principal: |
Rocha, Lorenzo Fogliarini da |
| Orientador(a): |
Skupien, Jovito Adiel |
| Banca de defesa: |
Blaya , Diego Segatto,
Scolari , Neimar |
| Tipo de documento: |
Dissertação
|
| Tipo de acesso: |
Acesso aberto |
| Idioma: |
por |
| Instituição de defesa: |
Universidade Franciscana
|
| Programa de Pós-Graduação: |
Mestrado em Ciências da Saúde e da Vida
|
| Departamento: |
Ciências da Saúde e da Vida
|
| País: |
Brasil
|
| Palavras-chave em Português: |
|
| Palavras-chave em Inglês: |
|
| Área do conhecimento CNPq: |
|
| Link de acesso: |
http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/1259
|
Resumo: |
Temporomandibular dysfunction (TMD) is one of the disorders that affects the stomatognathic system of patients, directly impacting their quality of life. The aim of this clinical study was to evaluate the effectiveness of a conservative approach using a combined pharmacological therapy of muscle relaxant (cyclobenzaprine hydrochloride) and anti-inflammatory (aceclofenac) for the treatment of temporomandibular dysfunction symptoms. Parameters such as mouth opening measurement and pain pressure threshold were utilized. Thirty-five patients were evaluated, comprising 20 in the test group and 15 in the placebo group, with 25 women and 10 men (40.1 ± 11.4 years). Both groups showed improved mouth opening, decreased intensity of provoked pain, and enhanced oral health-related quality of life (p < 0.001) in the first 14 days. However, between the second and third evaluations, there was no statistically significant improvement for any of the assessed outcomes. |
